Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$876,512
-$119,934 QoQ
Shares Held
36,400
+2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#1,402
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABLES CAPITAL MANAGEMENT INC. holds $11,549,324 across 11 Drug Manufacturers - General names. PFE ranks #4 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,805 | $3,364,401 | |
| 2 | JNJ |
Johnson & Johnson
|
12,302 | $3,124,338 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,302 | $2,094,807 | |
| 4 | PFE |
Pfizer Inc
This page
|
36,400 | $876,512 | |
| 5 | ABBV |
AbbVie Inc.
|
3,374 | $849,033 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,190 | $414,287 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,990 | $377,756 | |
| 8 | AMGN |
Amgen Inc
|
962 | $348,359 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $876,512 | 36,400 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $996,446 | 35,486 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $911,613 | 36,611 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $920,108 | 36,111 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $999,948 | 41,252 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,245,511 | 49,152 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,282,778 | 48,352 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,394,965 | 48,202 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,235,400 | 44,153 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,116,327 | 40,228 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,193,431 | 41,453 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,426,409 | 43,003 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,691,058 | 46,103 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,883,042 | 46,153 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,364,879 | 46,153 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,043,723 | 46,703 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,446,016 | 46,653 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,438,522 | 47,103 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,023,537 | 51,203 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,156,005 | 50,128 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,970,844 | 50,328 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,579,213 | 71,190 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,638,908 | 71,690 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,585,145 | 70,440 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,222,457 | 67,965 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $2,197,746 | 67,333 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||